Form 8-K - Current report:
SEC Accession No. 0001140361-26-014692
Filing Date
2026-04-15
Accepted
2026-04-15 08:54:03
Documents
15
Period of Report
2026-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20066669x2_8k.htm   iXBRL 8-K 34112
2 EXHIBIT 1.1 ny20066669x2_ex1-1.htm EX-1.1 292879
3 EXHIBIT 5.1 ny20066669x2_ex5-1.htm EX-5.1 11640
4 EXHIBIT 99.1 ny20066669x2_ex99-1.htm EX-99.1 22106
8 ny20066669x2_ex5-1logo01.jpg GRAPHIC 3257
  Complete submission text file 0001140361-26-014692.txt   574793

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tlry-20260415.xsd EX-101.SCH 3859
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20260415_lab.xml EX-101.LAB 21966
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20260415_pre.xml EX-101.PRE 16040
19 EXTRACTED XBRL INSTANCE DOCUMENT ny20066669x2_8k_htm.xml XML 4216
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray Brands, Inc. (Filer) CIK: 0001731348 (see all company filings)

EIN.: 824310622 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 26862658
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)